Repligen | الأصول



Assets تغيير تاريخ
Agilent USD 11.91B 68M 2025-01
Align Technology USD 6.1B 111.78M 2025-03
Bio Techne USD 2.67B 65.59M 2024-12
BioMarin Pharmaceutical USD 6.99B 137.74M 2024-12
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Bruker USD 5.81B 302.5M 2024-12
Charles River Laboratories USD 7.53B 475.5M 2024-12
Danaher USD 79.12B 1.57B 2025-03
Dentsply International USD 5.75B 873M 2024-12
Exact Sciences USD 5.93B 820.43M 2024-12
General Electric USD 124.12B 983M 2025-03
Henry Schein USD 10.22B 387M 2024-12
Illumina USD 6.3B 289M 2024-12
IQVIA Holdings USD 26.9B 281M 2024-12
Mettler Toledo International USD 3.24B 79.83M 2024-12
Myriad Genetics USD 1.03B 53.7M 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Repligen USD 2.85B 22.48M 2025-03
Revvity USD 12.36B 31.75M 2025-03
Standard Biotools USD 612.34M 69.19M 2024-12
Thermo Fisher Scientific USD 99.04B 1.72B 2025-03
Waters USD 4.55B 42.18M 2024-12
West Pharmaceutical Services USD 3.62B 25.2M 2025-03



Repligen الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.